212 related articles for article (PubMed ID: 29743097)
1. Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan.
Pakkanen SAE; de Vries A; Raekallio MR; Mykkänen AK; Palviainen MJ; Sankari SM; Vainio OM
Acta Vet Scand; 2018 May; 60(1):27. PubMed ID: 29743097
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-2-adrenoceptor agonism and antagonism on equine blood insulin and glucose concentrations after oral carbohydrate load.
Hallman IAM; Raekallio MR; Koho N; Weckman MJ; Karikoski NP
Vet J; 2024 Apr; 304():106080. PubMed ID: 38360134
[TBL] [Abstract][Full Text] [Related]
3. Effect of constant rate infusion of detomidine with and without vatinoxan on blood glucose and insulin concentrations in horses.
Hallman I; Tapio H; Raekallio M; Karikoski N
Vet Anaesth Analg; 2024; 51(2):144-151. PubMed ID: 38103967
[TBL] [Abstract][Full Text] [Related]
4. The effects of an alpha-2-adrenoceptor agonist, antagonist, and their combination on the blood insulin, glucose, and glucagon concentrations in insulin sensitive and dysregulated horses.
Box JR; Karikoski NP; Tanskanen HE; Raekallio MR
Vet J; 2021 Mar; 269():105610. PubMed ID: 33593492
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects and pharmacokinetic variables of romifidine and the peripheral α
de Vries A; Pakkanen SA; Raekallio MR; Ekiri A; Scheinin M; Taylor PM; Vainio OM
Vet Anaesth Analg; 2016 Nov; 43(6):599-610. PubMed ID: 26918855
[TBL] [Abstract][Full Text] [Related]
6. Blood glucose, acid-base and electrolyte changes during loading doses of alpha₂-adrenergic agonists followed by constant rate infusions in horses.
Ringer SK; Schwarzwald CC; Portier K; Mauch J; Ritter A; Bettschart-Wolfensberger R
Vet J; 2013 Dec; 198(3):684-9. PubMed ID: 24215780
[TBL] [Abstract][Full Text] [Related]
7. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral α-2 adrenoceptor antagonist.
Restitutti F; Raekallio M; Vainionpää M; Kuusela E; Vainio O
Vet J; 2012 Aug; 193(2):481-5. PubMed ID: 22277719
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of intravenous romifidine and propranolol administered alone or in combination for equine sedation.
Cenani A; Brosnan RJ; Madigan S; Knych HK; Madigan JE
Vet Anaesth Analg; 2017 Jan; 44(1):86-97. PubMed ID: 27426730
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and selected pharmacodynamics of romifidine following low-dose intravenous administration in combination with exercise to quarter horses.
Knych HK; Stanley SD; McKemie DS; Steinmetz SJ
J Vet Pharmacol Ther; 2017 Oct; 40(5):569-574. PubMed ID: 28097665
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Wojtasiak-Wypart M; Soma LR; Rudy JA; Uboh CE; Boston RC; Driessen B
J Vet Pharmacol Ther; 2012 Oct; 35(5):478-88. PubMed ID: 22233529
[TBL] [Abstract][Full Text] [Related]
11. Short-term effect of ovariectomy on measures of insulin sensitivity and response to dexamethasone administration in horses.
Bertin FR; Pader KS; Lescun TB; Sojka-Kritchevsky JE
Am J Vet Res; 2013 Dec; 74(12):1506-13. PubMed ID: 24274888
[TBL] [Abstract][Full Text] [Related]
12. Preliminary investigation of concurrent administration of phenylbutazone and romifidine in healthy horses.
Kruger K; Stegmann GF; Becker PJ
Vet Anaesth Analg; 2011 Sep; 38(5):505-9. PubMed ID: 21831057
[TBL] [Abstract][Full Text] [Related]
13. Oral and intravenous carbohydrate challenges decrease active ghrelin concentrations and alter hormones related to control of energy metabolism in horses.
Gordon ME; McKeever KH
J Anim Sci; 2006 Jul; 84(7):1682-90. PubMed ID: 16775051
[TBL] [Abstract][Full Text] [Related]
14. Effects on cardiopulmonary function and oxygen delivery of doses of romifidine and xylazine followed by constant rate infusions in standing horses.
Ringer SK; Schwarzwald CC; Portier KG; Ritter A; Bettschart-Wolfensberger R
Vet J; 2013 Feb; 195(2):228-34. PubMed ID: 22841452
[TBL] [Abstract][Full Text] [Related]
15. Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.
Tapio H; Raekallio MR; Mykkänen A; Männikkö S; Scheinin M; Bennett RC; Vainio O
Equine Vet J; 2019 Sep; 51(5):646-652. PubMed ID: 30793362
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variation in serum concentrations of selected metabolic hormones in horses.
Place NJ; McGowan CM; Lamb SV; Schanbacher BJ; McGowan T; Walsh DM
J Vet Intern Med; 2010; 24(3):650-4. PubMed ID: 20384949
[TBL] [Abstract][Full Text] [Related]
17. The effect of detomidine and its antagonism with tolazoline on stress-related hormones, metabolites, physiologic responses, and behavior in awake ponies.
Carroll GL; Matthews NS; Hartsfield SM; Slater MR; Champney TH; Erickson SW
Vet Surg; 1997; 26(1):69-77. PubMed ID: 9123816
[TBL] [Abstract][Full Text] [Related]
18. Effect of butorphanol, midazolam or ketamine on romifidine based sedation in horses during standing cheek tooth removal.
Müller TM; Hopster K; Bienert-Zeit A; Rohn K; Kästner SBR
BMC Vet Res; 2017 Dec; 13(1):381. PubMed ID: 29212478
[TBL] [Abstract][Full Text] [Related]
19. INTRAVENOUS VATINOXAN IN MARKHORS (
Sainmaa S; Mykkänen A; Adam M; Jantunen N; Vainio O; Raekallio M
J Zoo Wildl Med; 2019 Mar; 50(1):159-166. PubMed ID: 31120674
[TBL] [Abstract][Full Text] [Related]
20. Effects of vatinoxan in rats sedated with a combination of medetomidine, midazolam and fentanyl.
Lindh E; Meller A; Raekallio M
Acta Vet Scand; 2024 May; 66(1):23. PubMed ID: 38822394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
